Topic guide
Articles and reference material connected to this topic, organised for clear reading.
Reading path
For the primary endpoint, retatrutide lowered A1C by an average of 1.7% to 2.0% across doses at 40 weeks in TRANSCEND-T2D-1 Participants taking retatrutide 12 mg lost an average of 36.6 lbs (16.8%) No weight l…
Read guide →Share on Pinterest A new experimental weight loss drug from Eli Lilly shows dramatic results that rival current GLP-1 drugs and bariatric surgery. Image Credit: Scott Olson/Getty Images Eli Lilly recently anno…
Read guide →Sources point to a single instance in which experimental therapy retatrutide was provided for ‘compassionate use’ Alex Hogan/STAT Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship be…
Read guide →An article from Dive Brief // Obesity drugs Participants who stayed on the drug lost around one-quarter of their body weight, potentially setting a new benchmark for rivals like Novo Nordisk. Published May 21,…
Read guide →